classic situation of whereby the stock has been so cheap and the options are yet to catchpeople sellling into a huge discounti just bought some more at 1.5 for the record
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%